Hey All, Sorry I've been away from writing here so long. Work is killing me...but what else is new? I blog for my company also and that makes it difficult to keep writing, although I prefer to write independently and very much enjoy the conversations we have here. I am always happy to answer your questions about the biotech industry and careers. You can contact me @suzyscientist if you would like advice or feedback and I'll try to reply to you as soon as I can. Many thanks and kindest regards to all!
My posts are presented as opinion and commentary and do not represent the views of LabSpaces Productions, LLC, my employer, or my educational institution.
Please wait while my tweets load
For those of you who follow the tweets of @DivaBiotech, you are already familiar with the varied interests and activities of outgoing world traveler and international marketing guru in the area of genomics, Ruby Gadelrab. Ruby is one of my favorite tweeps, keeping me up to date on the personal genomics scene and the latest biotech science news. I asked Ruby to guest post on LabSpaces so we can hear more from this former molecular biologist turned marketing executive supertalent. Her background and experiences in biotech and her love for cutting edge science make her an excellent source of information and inspiration for up-and-coming biotech scientists.
Thank you Ruby for sharing this article with us. I hope we can print Part 2, when you report the results of your genetic profile. Depending on what comes back, I may do the same.
During the summer of 2009, I came across a fascinating Genetic Study that I decided to participate in. Part 1 of this blog will describe the study and some of its features I particularly liked. In Part 2, I will share some of my personal experiences in participating in the study.
The Coriell Personalized Medicine Collaborative (CPMC) is a research study with a goal of understanding if personalized genetic information can be used to improve health outcomes.
Participants are asked to contribute a Saliva Sample (by spitting a lot in a plastic tube) which is then screened for genetic variants, which can be attributable to common diseases and predict responses to certain medications.
The participants are also asked to complete an online profile of themselves in which they are asked a series of questions on their lifestyle, family history, current health and medications used. This information in combination with the test is used to generate a personalized genetic report which is viewable by the participant online, once the results are available. That’s it – it’s free and it’s really simple.
I wanted to highlight a few of the features of the study that I particularly liked
Once I heard about the CPMC and researched it a little, it didn’t take me long to decide that I wanted to participate. In Future posts I will share with you my 23andme experience as well as some of my results.
I would love to hear from others who decided to take a Personalized Genomics/Medicine test.
For further details on the study please visit
This post has been viewed: 774 time(s)
Cool, this sounds sort of like what Misha Angrist did in the Personal Genome Project that George Church's lab runs except that participants genomes were placed online.
Is the data output comparable to 23andMe? How are they offsetting the cost of a free test? Are non-profits going to have to pay for access to the database?
It sounds like an interesting model and it will be really nice to see your follow up post including your analyzed results.
Happy New Year! Sorry about the delay in getting back to you - I have been little tied up over the holidays.
@genomicrepairman - I believe that Misha Angrist actually had his whole genome sequenced and placed it online. I have just had genome wide genotyping. I am also willing to share my genome with anyone who wants to data crunch :)
@Brian - yes its comparable to the way 23andme does genome scanning, most of the results are concordant there are a few that differ slightly - ill write a separate post to compare and contrast. Because this is a research study, I believe they are funded from NIH grants.
Divabiotech (Ruby Gadelrab)